{"id":"https://openalex.org/W2118100404","doi":"https://doi.org/10.2174/1381612043382774","title":"Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents","display_name":"Structurally Modified Analogues of Glucagon-Like Peptide-1 (GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) As Future Antidiabetic Agents","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W2118100404","doi":"https://doi.org/10.2174/1381612043382774","mag":"2118100404","pmid":"https://pubmed.ncbi.nlm.nih.gov/15579061"},"language":"en","primary_location":{"id":"doi:10.2174/1381612043382774","doi":"https://doi.org/10.2174/1381612043382774","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612043382774","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118100404"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101547213","display_name":"Brian Green","orcid":"https://orcid.org/0000-0002-8087-6509","observed_orcids":["https://orcid.org/0000-0002-8087-6509"]},"institutions":[{"id":"https://openalex.org/I138801177","display_name":"University of Ulster","ror":"https://ror.org/01yp9g959","country_code":"GB","type":"education","lineage":["https://openalex.org/I138801177"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Brian Green","raw_affiliation_strings":["School of Biomedical Sciences, University of Ulster, Coleraine, BT52 1SA, Northern Ireland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Ulster, Coleraine, BT52 1SA, Northern Ireland, UK","institution_ids":["https://openalex.org/I138801177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013136657","display_name":"Victor A. Gault","orcid":"https://orcid.org/0000-0001-8501-1013","observed_orcids":["https://orcid.org/0000-0001-8501-1013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Gault","raw_affiliation_strings":["School of Biomedical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006863322","display_name":"Finbarr P.M. O'Harte","orcid":"https://orcid.org/0000-0002-7199-4239","observed_orcids":["https://orcid.org/0000-0002-7199-4239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Finbarr O'Harte","raw_affiliation_strings":["School of Biomedical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064124957","display_name":"Peter R. Flatt","orcid":"https://orcid.org/0000-0001-8548-7943","observed_orcids":["https://orcid.org/0000-0001-8548-7943"]},"institutions":[{"id":"https://openalex.org/I138801177","display_name":"University of Ulster","ror":"https://ror.org/01yp9g959","country_code":"GB","type":"education","lineage":["https://openalex.org/I138801177"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Flatt","raw_affiliation_strings":["School of Biomedical Sciences, University of Ulster, Coleraine, BT52 1SA, Northern Ireland,United Kingdom.,Ireland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Ulster, Coleraine, BT52 1SA, Northern Ireland,United Kingdom.,Ireland","institution_ids":["https://openalex.org/I138801177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8078,"has_fulltext":false,"cited_by_count":117,"citation_normalized_percentile":{"value":0.9655073,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"29","first_page":"3651","last_page":"3662"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9490000009536743},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9700000286102295},{"id":"https://openalex.org/keywords/glp-1-analogues","display_name":"GLP-1 analogues","score":0.9100000262260437},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8180000185966492},{"id":"https://openalex.org/keywords/incretin-hormones","display_name":"incretins","score":0.7120000123977661},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.5529999732971191},{"id":"https://openalex.org/keywords/camp","display_name":"cyclic AMP","score":0.6869999766349792},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.5509999990463257},{"id":"https://openalex.org/keywords/n-terminal-modification","display_name":"N-terminal modification","score":0.6610000133514404},{"id":"https://openalex.org/keywords/amino-acid-substitutions","display_name":"amino acid substitutions","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antidiabetic-activity","display_name":"antidiabetic activity","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.7533100247383118},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7082772254943848},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.6257885694503784},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5852525234222412},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.5359834432601929},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5243387818336487},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5208204984664917},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5023398399353027},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.48615261912345886},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4811493158340454},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4808812439441681},{"id":"https://openalex.org/C2777951760","wikidata":"https://www.wikidata.org/wiki/Q5526842","display_name":"Gastrointestinal hormone","level":4,"score":0.4533126652240753},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.44059526920318604},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4361039102077484},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38824763894081116},{"id":"https://openalex.org/C56191518","wikidata":"https://www.wikidata.org/wiki/Q416997","display_name":"Peptide hormone","level":3,"score":0.3141152858734131},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2899596095085144},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2641316056251526},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.258775532245636},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.24475803971290588},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24053862690925598},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.17265039682388306},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08388710021972656}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/1381612043382774","doi":"https://doi.org/10.2174/1381612043382774","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1381612043382774","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:15579061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15579061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/abac573c-6067-4722-84e4-99fbc996795f","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/abac573c-6067-4722-84e4-99fbc996795f","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Green, B 2004, 'Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents.', Current Pharmaceutical Design, vol. 10(29), no. 29, pp. 3651-3662.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":116,"referenced_works":["https://openalex.org/W655431975","https://openalex.org/W1532339656","https://openalex.org/W1599202069","https://openalex.org/W1607232966","https://openalex.org/W1608351814","https://openalex.org/W1881703484","https://openalex.org/W1963520641","https://openalex.org/W1964212912","https://openalex.org/W1970429748","https://openalex.org/W1970964150","https://openalex.org/W1971103360","https://openalex.org/W1976837127","https://openalex.org/W1978953702","https://openalex.org/W1978959127","https://openalex.org/W1979535675","https://openalex.org/W1979613556","https://openalex.org/W1980417498","https://openalex.org/W1985921802","https://openalex.org/W1986331352","https://openalex.org/W1986522335","https://openalex.org/W1991477535","https://openalex.org/W1992411188","https://openalex.org/W1992773726","https://openalex.org/W1993026259","https://openalex.org/W1993351024","https://openalex.org/W1996796636","https://openalex.org/W1997792880","https://openalex.org/W2000465889","https://openalex.org/W2002147281","https://openalex.org/W2003141714","https://openalex.org/W2005468519","https://openalex.org/W2006403332","https://openalex.org/W2008082500","https://openalex.org/W2008411184","https://openalex.org/W2009428928","https://openalex.org/W2010874570","https://openalex.org/W2013171650","https://openalex.org/W2013898766","https://openalex.org/W2019099090","https://openalex.org/W2022101780","https://openalex.org/W2024308165","https://openalex.org/W2025485914","https://openalex.org/W2028479574","https://openalex.org/W2030347165","https://openalex.org/W2031468509","https://openalex.org/W2038087075","https://openalex.org/W2048279628","https://openalex.org/W2050133162","https://openalex.org/W2051743127","https://openalex.org/W2052332602","https://openalex.org/W2053671144","https://openalex.org/W2054764073","https://openalex.org/W2056533803","https://openalex.org/W2056594490","https://openalex.org/W2060409973","https://openalex.org/W2061274996","https://openalex.org/W2061393168","https://openalex.org/W2062109893","https://openalex.org/W2064721546","https://openalex.org/W2065869166","https://openalex.org/W2068361325","https://openalex.org/W2069917285","https://openalex.org/W2070823215","https://openalex.org/W2075404533","https://openalex.org/W2076880341","https://openalex.org/W2079361682","https://openalex.org/W2080128749","https://openalex.org/W2081392051","https://openalex.org/W2083447185","https://openalex.org/W2085760982","https://openalex.org/W2087707716","https://openalex.org/W2089109393","https://openalex.org/W2090007082","https://openalex.org/W2091157148","https://openalex.org/W2092561092","https://openalex.org/W2095130937","https://openalex.org/W2095327052","https://openalex.org/W2097018460","https://openalex.org/W2097717126","https://openalex.org/W2100614900","https://openalex.org/W2102392334","https://openalex.org/W2102977341","https://openalex.org/W2103040459","https://openalex.org/W2104239190","https://openalex.org/W2104678245","https://openalex.org/W2105096600","https://openalex.org/W2109242743","https://openalex.org/W2111216775","https://openalex.org/W2111865924","https://openalex.org/W2114369058","https://openalex.org/W2114583988","https://openalex.org/W2115306377","https://openalex.org/W2118889627","https://openalex.org/W2121979674","https://openalex.org/W2124182221","https://openalex.org/W2128979121","https://openalex.org/W2130229274","https://openalex.org/W2134534032","https://openalex.org/W2141264129","https://openalex.org/W2143847100","https://openalex.org/W2144546532","https://openalex.org/W2145140318","https://openalex.org/W2146232529","https://openalex.org/W2147679298","https://openalex.org/W2151322171","https://openalex.org/W2154615287","https://openalex.org/W2155633307","https://openalex.org/W2160865447","https://openalex.org/W2161923520","https://openalex.org/W2162768091","https://openalex.org/W2163092495","https://openalex.org/W2165736145","https://openalex.org/W2170232513","https://openalex.org/W2171404549","https://openalex.org/W2315268720","https://openalex.org/W2463198705"],"related_works":["https://openalex.org/W2025485914","https://openalex.org/W2010874570","https://openalex.org/W2114369058","https://openalex.org/W2108420279","https://openalex.org/W1985921802","https://openalex.org/W2092365519","https://openalex.org/W2144546532","https://openalex.org/W1902646265","https://openalex.org/W2105096600","https://openalex.org/W2103040459"],"abstract_inverted_index":{"Glucagon-like":[0],"peptide-1(7-36)amide":[1],"(GLP-1)":[2],"and":[3,51,77,101,117,126,138,144,178,223,235],"glucose-dependent":[4,25],"insulinotropic":[5],"polypeptide":[6],"(GIP)":[7],"are":[8,24],"gastrointestinal":[9],"insulin-releasing":[10],"hormones":[11,23],"involved":[12],"in":[13,57,87,114,182],"the":[14,40,65,72,88,115,133,149,210,213,220,230,251],"regulation":[15],"of":[16,27,34,43,49,67,75,119,124,135,142,148,198,212,219],"postprandial":[17],"nutrient":[18],"homeostasis.":[19,46],"These":[20],"two":[21],"incretin":[22],"stimulators":[26],"pancreatic":[28],"beta-cell":[29],"function,":[30],"exhibiting":[31],"a":[32,195],"spectrum":[33],"secondary":[35],"extrapancreatic":[36],"activities,":[37,200],"which":[38,208],"favour":[39],"efficient":[41],"control":[42],"blood":[44],"glucose":[45],"Such":[47],"actions":[48],"GLP-1":[50,76,125,143,222],"GIP":[52,78,145,224],"have":[53],"generated":[54],"considerable":[55],"interest":[56],"their":[58,84,105],"possible":[59,80],"exploitation":[60],"as":[61,79,175],"novel":[62],"agents":[63],"for":[64,232,238],"treatment":[66],"type":[68,183,239],"2":[69,184,240],"diabetes.":[70,185],"Despite":[71],"many":[73],"attributes":[74],"future":[81],"antidiabetic":[82,217],"agents,":[83],"rapid":[85],"degradation":[86],"circulation":[89],"by":[90,250],"dipeptidyl":[91],"peptidase":[92],"IV":[93,151],"(DPP":[94],"IV)":[95],"to":[96,132,157,162,168,206,228],"inactive":[97],"truncated":[98],"forms":[99],"GLP-1(9-36)amide":[100],"GIP(3-42),":[102],"severely":[103],"limits":[104],"therapeutic":[106],"usefulness.":[107],"This":[108,243],"review":[109],"will":[110,129,187],"consider":[111],"recent":[112],"developments":[113],"design":[116],"effectiveness":[118],"synthetic":[120],"DPP":[121,150],"IV-resistant":[122],"analogues":[123,205,225],"GIP.":[127],"Consideration":[128],"be":[130,188],"given":[131],"effects":[134],"N-terminal":[136],"modification":[137,192],"amino":[139],"acid":[140],"substitution":[141],"either":[146],"side":[147],"cleavage":[152],"site":[153],"on":[154],"(i)":[155],"susceptibility":[156],"enzymatic":[158],"degradation,":[159],"(ii)":[160],"binding":[161],"native":[163,214],"hormone":[164],"receptor,":[165],"(iii)":[166],"ability":[167],"elevate":[169],"intracellular":[170],"cyclic":[171],"AMP,":[172],"(iv)":[173],"potency":[174],"insulin":[176],"secretagogues,":[177],"(v)":[179],"antihyperglycaemic":[180],"activity":[181,211],"It":[186],"shown":[189],"that":[190],"structural":[191],"can":[193],"produce":[194],"varied":[196],"set":[197],"biological":[199],"ranging":[201],"from":[202],"more":[203],"efficacious":[204],"those":[207],"antagonise":[209],"hormone.":[215],"The":[216],"properties":[218],"best":[221],"indeed":[226],"promise":[227],"provide":[229],"basis":[231],"novel,":[233],"effective":[234],"long-acting":[236],"drugs":[237],"diabetes":[241],"therapy.":[242],"approach":[244],"is":[245],"currently":[246],"being":[247],"pursued":[248],"actively":[249],"pharmaceutical":[252],"industry.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118100404","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
